Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: Effect of mupirocin ointment

Journal of the American Society of Nephrology

Volumn 9, Issue 6, 1998, Pages 1085-1092

  Sesso, Ricardo ^a   Barbosa, Dulce ^a   Leme, Ivani L ^a   Sader, Helio ^a   Canziani, Maria E ^a   Manfredi, Silvia ^a   Draibe, Sergio ^a   Pignatari, Antonio C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

POVIDONE IODINE; PSEUDOMONIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SKIN DECONTAMINATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOPICAL DRUG ADMINISTRATION;

EID: 0031801450     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v961085     Document Type: Article

References (41)

1. Uldall PR, Dyck RF, Woods RN: A subclavian cannula for temporary vascular access for hemodialysis or plasmapheresis. Dial Transplant 8: 963-968, 1979
2. Sherertz RJ, Falk RJ, Huffman KA, Thomann CA, Mattern WD: Infections associated with subclavian Uldall catheters. Arch Intern Med 143: 52-56, 1983
3. Kozeny GA, Venezio FR, Bansal VD, Vertuno LL, Hano JE: Incidence of subclavian dialysis catheter-related infections. Arch Intern Med 144: 1787-1789, 1984
4. Dahlberg PJ, Yutuc WR, Newcomer KL: Subclavian hemodialysis catheter infections. Am J Kidney Dis 7: 421-427, 1986
5. Vanherwegem J-L, Dhaene M, Goldman M, Stolear J-C, Sabot J-P, Waterlot Y, Srruys E, Thayse C: Infections associated with subclavian dialysis catheters: The key role of nurse training. Nephron 42: 116-119, 1986
6. Cheesbrough JS, Finch RG, Burden RP: A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis 154: 579-589, 1986
7. Vanholder R, Hoenich N, Ringoir S: Morbidity and mortality of central venous catheter hemodialysis: A review of 10 years' experience. Nephron 47: 274-279, 1987
8. Sesso R, Belasco AG: Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 11: 2417-2420, 1996
9. US Renal Data System: USRDS 1995 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, April, 1995
10. Goldman DA, Pier GB: Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev 6: 176-192, 1993
11. Benerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Toison J, Henderson T, Marione WJ: Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 91[Suppl 3B]: 86S-89S, 1991
12. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW: Staphylococcus aureus catheter-associated bacteremia. Arch Intern Med 155: 1161-1166, 1995
13. Maki DG: Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy. In: Infections Associated with Indwelling Medical Devices, edited by Bisno AL, Waldvogel FA, American Society for Microbiology, Washington, DC, 1989, pp 161-177
14. Hill RLR, Fisher AP, Ware RJ, Wilson S, Casewell MW: Mupirocin for the reduction of colonization of internal jugular cannulae: A randomized controlled trial. J Hosp Infect 15: 311-323, 1990
15. Casewell MW, Hill RLR: In vitro activity of mupirocin ("pseudomonic acid") against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 15: 523-531, 1985
16. Casewell MW, Hill RLR: Elimination of nasal carriage Staphylococcus aureus with mupirocin ("pseudomonic acid"): A controlled trial. J Antimicrob Chemother 17: 365-372, 1986
17. Gilbert M: Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol 20: 1083-1087, 1989
18. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, Wenzel RP: Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 114: 101-106, 1991
19. Maki DG, Weise CE, Serafin HW: A semiquantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 296: 1305-1309, 1977
20. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods, Lifetime Learning Publications, Belmont, CA, Wadsworth, 1982, pp 283-294
21. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall G: A prospective study of infections in hemodialysis patients: Patients hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 9: 534-541, 1988
22. Ena J, Boelaert JR, Doyken LD: Van Landuyt HW, Godard CA, Herwaldt LA: Epidemiology of Staphylococcus aureus infections in patients on hemodialysis. Infect Control Hosp Epidemiol 15: 78-81, 1994
23. Chow JW, Yu VL: Staphylococcus aureus nasal carriage in hemodialysis patients: Its role in infection and approaches to prophylaxis. Arch Intern Med 149: 1258-1262, 1989
24. Kirmani N, Tuazon CU, Murray HW, Parrish AE, Sheagren JN: Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 138: 1657-1659, 1978
25. Goldblum SE, Reed WP, Ulrich JA, Goldman RS: Staphylococcal carriage and infections in hemodialysis patients. Dial Transplant 7: 1140-1148, 1978
26. Yu VL, Goetz A, Ed MN, Wagener M, Smith PJB, Rihs JD, Hanchett J, Zuravleff JJ: Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: Efficacy of antibiotic prophylaxis. N Engl J Med 315: 91-96, 1986
27. Boelaert JR, van Landuyt HW, Godard CA, Daneels RF, Schurgers MI, Matthys EG, De Baere YA, Gheyle DW, Cordts BZ, Herwaldt LA: Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 8: 235-239, 1993
28. The Mupirocin Study Group: Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 7: 2403-2408, 1996
29. Uldall PR, Merchant N, Woods F, Yarworski U, Vas S: Changing subclavian hemodialysis cannulas to reduce infection [Letter]. Lancet 2: 1373, 1981
30. Levin A, Mason JM, Jindal KK, Fong W, Goldstein MB: Prevention of hemodialysis subclavian catheter infections by topical povidone-iodine. Kidney Int 40: 934-938, 1991
31. Dahlberg PJ, Agger WA, Singer JR, Yutuc WR, Newcomer KL, Schaper A, Rooney BL: Subclavian hemodialysis catheter infections: A prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 16: 506-511, 1995
32. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ: Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 62: 641-646, 1996
33. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127: 275-280, 1997
34. Moran JM, Atwood RP, Rowe MI: A clinical and bacteriologic study of infections associated with venous cutdowns. N Engl J Med 272: 554-560, 1965
35. Norden CW: Application of antibiotic ointment to the site of venous catheterization: A controlled trial. J Infect Dis 120: 611-615, 1969
36. Zinner SH, Denny-Brown BC, Braun P: Risk of infection with intravenous indwelling catheters: Effect of application of antibiotic ointment. J Infect Dis 120: 616-619, 1969
37. Maki DG, Band JD: A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 70: 739-744, 1981
38. Maki DG, Stolz SM, Wheeler S, Mermel LA: Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann Intern Med 127: 257-266, 1997
39. Raad I, Darouiche R, Duppuis J, Abi-Said D, Gabrielli A, Hachem R: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. Ann Intern Med 127: 267-274, 1997
40. Pearson ML: Guideline for prevention of intravascular device-related infections. Infect Control Hosp Epidemiol 17: 438-473, 1996
41. Cookson BD: Mupirocin resistance in Staphylococci. J Antimicrob Chemother 25: 497-503, 1990